Invesco Ltd. trimmed its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 76.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 335,066 shares of the company's stock after selling 1,090,508 shares during the period. Invesco Ltd. owned about 0.20% of Option Care Health worth $7,774,000 at the end of the most recent reporting period.
Other institutional investors have also modified their holdings of the company. Murphy & Mullick Capital Management Corp acquired a new stake in Option Care Health during the fourth quarter worth approximately $26,000. UMB Bank n.a. boosted its stake in Option Care Health by 41.7% in the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock worth $27,000 after buying an additional 346 shares during the last quarter. Signaturefd LLC grew its holdings in Option Care Health by 487.9% in the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company's stock valued at $28,000 after buying an additional 1,005 shares during the period. Quadrant Capital Group LLC lifted its holdings in shares of Option Care Health by 172.8% during the 4th quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock worth $40,000 after acquiring an additional 1,099 shares during the period. Finally, Blue Trust Inc. increased its position in Option Care Health by 16.9% during the fourth quarter. Blue Trust Inc. now owns 4,703 shares of the company's stock worth $109,000 after purchasing an additional 681 shares during the last quarter. Hedge funds and other institutional investors own 98.05% of the company's stock.
Wall Street Analysts Forecast Growth
A number of research firms have recently commented on OPCH. JPMorgan Chase & Co. raised their price objective on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a report on Thursday, March 6th. Barrington Research reissued an "outperform" rating and issued a $38.00 price objective on shares of Option Care Health in a research report on Monday, April 21st. Jefferies Financial Group raised Option Care Health from a "hold" rating to a "buy" rating and upped their target price for the stock from $26.00 to $35.00 in a research report on Thursday, January 23rd. Bank of America upgraded Option Care Health from a "neutral" rating to a "buy" rating and raised their target price for the company from $26.00 to $33.00 in a report on Monday, January 13th. Finally, JMP Securities reaffirmed a "market outperform" rating and set a $36.00 price target on shares of Option Care Health in a report on Tuesday, April 22nd. Two equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $33.75.
Check Out Our Latest Research Report on OPCH
Option Care Health Stock Performance
Shares of OPCH traded up $0.07 during midday trading on Monday, hitting $32.97. 2,800,639 shares of the stock traded hands, compared to its average volume of 1,780,957. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $35.53. The business's 50 day moving average price is $33.36 and its two-hundred day moving average price is $28.76. The firm has a market capitalization of $5.42 billion, a PE ratio of 27.71, a price-to-earnings-growth ratio of 2.30 and a beta of 1.07.
Insider Activity at Option Care Health
In other news, insider Michael Bavaro sold 30,996 shares of the company's stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the sale, the insider now directly owns 44,974 shares of the company's stock, valued at approximately $1,495,835.24. This represents a 40.80 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 0.64% of the stock is owned by insiders.
Option Care Health Profile
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Further Reading
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
